| abstract |
This invention provides a pharmaceutical aerosol formulation consisting essentially of S-salmeterol or a physiologically acceptable salt thereof as medicament, optionally one or more other medicaments, and 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoro-n-propane or a mixture thereof as propellant. |